Replies to post #7031 on InMed Pharmaceuticals Inc (INM)

[Flair09]

Please share 👇 with every doctor / neurologist / patient / politician / person who wants to better understand the efficacious agility of cannabinoid wellness.

IMO #cannabis biotech about to lead phase two of this secular 🐂 market. @CB1Caphttps://t.co/5tW74MIMZr

— Todd Harrison (@todd_harrison) October 18, 2018

[Gravis786]

This is inaccurate, this will not be above 1.30 before the end of the year. Nothing will happens until we are well into 2019. We need official announcement of clinical trials. This won’t pay until end of 2020 so sit tight and forget about it.